• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Absci Corporation - Common Stock (NQ:ABSI)

8.300 -0.100 (-1.19%)
Official Closing Price Updated: 4:00 PM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,769,956
Open 8.220
Bid (Size) 8.250 (100)
Ask (Size) 8.480 (200)
Prev. Close 8.400
Today's Range 8.130 - 8.550
52wk Range 2.240 - 12.05
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
July 14, 2026
From Absci Corporation
Via GlobeNewswire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
June 24, 2026
Via Chartmill

Performance

YTD
+129.9%
+129.9%
1 Month
-26.7%
-26.7%
3 Month
+44.3%
+44.3%
6 Month
+228.1%
+228.1%
1 Year
+185.2%
+185.2%

More News

Read More
Here are the top movers in Wednesday's session. ↗
June 24, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
June 24, 2026
Via Chartmill
Absci Corp (NASDAQ:ABSI) Plunges on 86% Q1 Revenue Miss Despite Clinical Advances ↗
May 07, 2026
Via Chartmill
Absci Corp. (NASDAQ:ABSI) Reports Mixed Q4 Results Amid Clinical Progress ↗
March 24, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday. ↗
June 24, 2026
Via Chartmill
News headline image
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
June 24, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
June 24, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
The 1 AI Stock I'd Put in a Time Capsule and Open in 2036 ↗
May 25, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Absci to Participate in Upcoming Investor Conferences
May 20, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci (ABSI) Q1 2026 Earnings Call Transcript ↗
May 07, 2026
Via The Motley Fool
Topics Earnings
News headline image
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
May 07, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
April 23, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci (ABSI) Q4 2025 Earnings Call Transcript ↗
March 25, 2026
Via The Motley Fool
Topics Earnings
What's going on in today's after hours session ↗
March 24, 2026
Via Chartmill
News headline image
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
March 24, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
March 24, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
March 03, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
February 24, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in Upcoming Investor Conferences
February 17, 2026
From Absci Corporation
Via GlobeNewswire
News headline image
AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months
February 06, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
From Absci Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Absci Corporation - Common Stock publicly traded?
Yes, Absci Corporation - Common Stock is publicly traded.
What exchange does Absci Corporation - Common Stock trade on?
Absci Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Absci Corporation - Common Stock?
The ticker symbol for Absci Corporation - Common Stock is ABSI on the Nasdaq Stock Market
What is the current price of Absci Corporation - Common Stock?
The current price of Absci Corporation - Common Stock is 8.300
When was Absci Corporation - Common Stock last traded?
The last trade of Absci Corporation - Common Stock was at 08/06/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap